A conjugate formed by a HSP90 inhibition peptide and cytotoxic agent via linker conjugation and usage thereof in preparing medicine for preventing and/or treating tumor. The conjugate has three anti-tumor effects including targeting delivery, chemistry treatment and tumor destruction, and can increase a drug capability of destroying the tumor. A reduction in relative dosage can obviously reduce the toxicity induced by accumulation of chemotherapy drugs.
